This article is more than 5 years old. Information may no longer be current.

SLT lowered IOP, medication use in Hispanic population, study finds

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

PRAGUE — Selective laser trabeculoplasty reduced IOP by 30% in primary-treated eyes and 24% in secondary-treated eyes, a study found.

Lawrence F. Jindra, MD, and colleagues performed a retrospective chart review of 88 eyes of Hispanic patients from a consecutive case series of 3,034 eyes treated with SLT over 9 years. Cases were divided into two groups according to therapy methods. There were 54 eyes in the primary group and 34 eyes in the secondary group.

The study was presented as a poster at the winter meeting of the European Society of Cataract and Refractive Surgeons.

In the primary group, mean IOP decreased from 18.8 mm Hg to 13.2 mm Hg, and in the secondary group, it decreased from 18.5 mm Hg to 14 mm Hg.

"In this large long-term clinical series, in patients of Hispanic race, selective laser trabeculoplasty, as primary or secondary therapy, decreased intraocular pressure and reduced the number of medications used in patients with glaucoma," Dr. Jindra and colleagues said.

• Disclosure: Dr. Jindra has independently conducted and financed the clinical research presented and received honoraria from Ellex in the last year. The other study authors have no relevant financial disclosures.